PUBLIX SUPER MARKETS INC 250 mg/1
ACETAMINOPHEN, ASPIRIN and CAFFEINE · TABLET · PUBLIX SUPER MARKETS INC
PUBLIX SUPER MARKETS INC is a tablet containing acetaminophen, aspirin and caffeine at 250 mg/1, taken oral. Manufactured by PUBLIX SUPER MARKETS INC.
Key Facts
- Brand Name
- PUBLIX SUPER MARKETS INC
- Generic Name
- ACETAMINOPHEN, ASPIRIN and CAFFEINE
- NDC Code (Product)
56062-305- Manufacturer
- PUBLIX SUPER MARKETS INC
- Strength
- 250 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA214039
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 02/23/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is PUBLIX SUPER MARKETS INC used for?
PUBLIX SUPER MARKETS INC contains ACETAMINOPHEN, ASPIRIN and CAFFEINE. It is a tablet taken oral. Consult your doctor for specific uses.
Is PUBLIX SUPER MARKETS INC a controlled substance?
PUBLIX SUPER MARKETS INC is not classified as a controlled substance by the DEA.
What is the generic name for PUBLIX SUPER MARKETS INC?
The generic name for PUBLIX SUPER MARKETS INC is ACETAMINOPHEN, ASPIRIN and CAFFEINE. There are 12 other brand versions of ACETAMINOPHEN, ASPIRIN and CAFFEINE.
What is the NDC code for PUBLIX SUPER MARKETS INC 250 mg/1?
The NDC (National Drug Code) for PUBLIX SUPER MARKETS INC 250 mg/1 is 56062-305, listed by PUBLIX SUPER MARKETS INC.
Other Acetaminophen, Brands
See all →- Pain Reliever Extra Strength250 mg/111822-1590
- Migraine Relief250 mg/172036-305
- ACETAMINOPHEN ASPIRIN AND CAFFEINE250 mg/121130-074
- ACETAMINOPHEN ASPIRIN AND CAFFEINE250 mg/158602-817
- Headache Relief Extra Strength250 mg/149035-433
- Acetaminophen, Aspirin and Caffeine250 mg/157237-348
- Headache Relief Extra Strength250 mg/157243-334
- Migraine Relief250 mg/181522-205
- ACETAMINOPHEN ASPIRIN AND CAFFEINE250 mg/179903-216
- Migraine Relief250 mg/153943-305
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)